Post-TBI Irritability and Aggression: Building Evidence-Based Approaches to Management
F
Flora Hammond, MD
Primary Investigator
Recruiting
18-70 years
All
Phase
N/A
3 Locations
Brief description of study
The purpose of the study is to see if buspirone is effective in treating irritability and aggression in people who have had a traumatic brain injury.
Detailed description of study
The purpose of the study is to see if buspirone is effective in treating irritability and aggression in people who have had a traumatic brain injury.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Traumatic Brain Injury,1210009885
-
Age: Between 18 Years - 70 Years
-
Gender: All
Inclusion Criteria
Closed head injury at least 6 months prior to enrollment
Irritability/aggression
Observer with whom subject interacts sufficiently to observe occurences of irritability
Exclusion Criteria
Ingestion of buspirone during the month prior to enrollment
History of schizophrenia or psychosis
Uncontrolled seizure disorder
Additional Information:Closed head injury at least 6 months prior to enrollment
Irritability/aggression
Observer with whom subject interacts sufficiently to observe occurences of irritability
Exclusion Criteria
Ingestion of buspirone during the month prior to enrollment
History of schizophrenia or psychosis
Uncontrolled seizure disorder
Participants will be paid for their participation.
Updated on
01 Aug 2024.
Study ID: 1210009885
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
